University of Pennsylvania
508 articles about University of Pennsylvania
Verismo Therapeutics and University of Pennsylvania Discover Two Novel Binders Targeting CD19; Enter Licensing Agreement
Verismo Therapeutics , a clinical-stage CAR T company, Penn spinout, and pioneer of the novel KIR-CAR platform technology, today announced that it had entered into a licensing agreement with the University of Pennsylvania.
Soligenix, Inc. announced today that patient enrollment has been opened for the investigator-initiated study (IIS) at the University of Pennsylvania, supported by a $2.6 million Orphan Products Development grant award by the U.S. Food and Drug Administration (FDA).
Interpersonal and Structural Stigma Toward Sexual Minority Youth Create Mental Health Challenges, Increased Suicide Risk
Researchers from Children's Hospital of Philadelphia and the University of Pennsylvania found that lesbian, gay and bisexual youth experienced more interpersonal discrimination based on others perceiving them as lesbian, gay, or bisexual and were four times more likely to attempt suicide.
Candel revealed a collaboration with the University of Pennsylvania to assess the combination of Candel’s viral immunotherapy and UPenn’s CAR-T cell treatments in solid tumor models.
ONI and the University of Pennsylvania Start Research Collaboration to Identify Unique Biomarkers and Characteristics to Guide Next Generation CAR-T Development
ONI, a single-molecule imaging platform biotech, announced a research collaboration with the University of Pennsylvania, one of the true pioneers of CAR-T research and clinical trials.
Sponsored Research Agreement (SRA) with Penn advances multichain KIR-CAR platform targeting solid tumors.
Researchers continue to explore how to turn deadly venom into life-saving drugs. Several papers on the subject have recently been published and BioSpace is taking a look at them.
CAR-T cell therapy is still a time-consuming and expensive process. But researchers may have just solved the turnaround-time challenge for CAR-T.
COVID-19 cases are soaring in China, Hong Kong, the U.K. and parts of Europe. A recent Demy-Colton Virtual Salon explored what we can expect in the near future.
While the "speed of science" to develop a successful coronavirus vaccine against the novel COVID-19 has been record-setting, scientists are telling us it's not enough.
Navidea Biopharmaceuticals Announces Research Agreement with the University of Pennsylvania Evaluating Tc99m Tilmanocept as a Prognostic Marker for Glioblastoma
Navidea Biopharmaceuticals, Inc. today announced the signing of a Sponsored Research Agreement with the University of Pennsylvania (“Penn”) for a project to evaluate the use of Tc99m tilmanocept imaging in glioblastoma.
A new study published in the journal Nature found that two patients with leukemia who were treated with CAR T-cell therapy are still in remission 10 years later.
Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty
Alligator Bioscience announced the initiation a sponsored research collaboration to study biomarker data from Alligator's OPTIMIZE-1 study with the University of Pennsylvania's Pancreatic Cancer Research Center.
Beatrice Mintz, the research legend passed away at the age of 100. Her contribution to the field is unforgettable. ere's more about her and the research.
Scientists from the University of Pennsylvania developed a new approach to address fibrosis, a leading cause of heart disease.
A team of researchers has developed an mRNA-based Lyme vaccine that aims to prevent Lyme disease by deterring the tick itself. And here's how effective it is.
iECURE Partners to Develop Next-Generation Liver-Targeted Lipid Nanoparticles with University of Pennsylvania
iECURE today announced that it has entered into an exclusive agreement with the University of Pennsylvania (Penn) to develop next-generation lipid nanoparticles (LNP) for liver gene editing applications.
The U.S. CDC has issued new travel warnings as surges of COVID-19 continue throughout the country and the world. For that and other COVID-19 news, read below.
Nordic Nanovector enters research collaboration with the University of Pennsylvania to generate a novel CD37-targeting CAR-T cell approach
Nordic Nanovector ASA is pleased to announce that it has entered into a research collaboration with the University of Pennsylvania to generate a CD37-targeting CAR-T cell approach as a potential treatment for patients with B-cell malignancies.
June really broke out in 2012 when he saved the life of Emily Whitehead, a child suffering from relapsed acute lymphoblastic leukemia (ALL), with CD19 CAR-T.